Literature DB >> 29149697

Characteristics of motor speech phenotypes in multiple sclerosis.

Jan Rusz1, Barbora Benova2, Hana Ruzickova2, Michal Novotny3, Tereza Tykalova3, Jan Hlavnicka3, Tomas Uher2, Manuela Vaneckova4, Michaela Andelova2, Klara Novotna2, Lucie Kadrnozkova2, Dana Horakova2.   

Abstract

BACKGROUND: Motor speech disorders in multiple sclerosis (MS) are poorly understood and their quantitative, objective acoustic characterization remains limited. Additionally, little data regarding relationships between the severity of speech disorders and neurological involvement in MS, as well as the contribution of pyramidal and cerebellar functional systems on speech phenotypes, is available.
METHODS: Speech data were acquired from 141 MS patients with Expanded Disability Status Scale (EDSS) ranging from 1 to 6.5 and 70 matched healthy controls. Objective acoustic speech assessment including subtests on phonation, oral diadochokinesis, articulation and prosody was performed.
RESULTS: The prevalence of dysarthria in our MS cohort was 56% while the severity was generally mild and primarily consisted of a combination of spastic and ataxic components. Prosodic-articulatory disorder presenting with monopitch, articulatory decay, excess loudness variations and slow rate was the most salient. Speech disorders reflected subclinical motor impairment with 78% accuracy in discriminating between a subgroup of asymptomatic MS (EDSS < 2.0) and control speakers. Speech disorder severity was related to the severity of neurological involvement. Decreased articulation rate was moderately correlated to EDSS as well as all subtests of the multiple sclerosis functional composite. The strongest correlation was observed between irregular oral diadochokinesis and the 9-Hole Peg Test (r = - 0.65, p < 0.001). Irregular oral diadochokinesis and excess loudness variations significantly separated pure pyramidal and mixed pyramidal-cerebellar MS subgroups.
CONCLUSIONS: Automated speech analyses may provide valuable biomarkers of disease progression in MS as dysarthria represents common and early manifestation that reflects disease disability and underlying pyramidal-cerebellar pathophysiology.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acoustic analyses; Dysarthria; Multiple sclerosis; Speech; Voice

Mesh:

Year:  2017        PMID: 29149697     DOI: 10.1016/j.msard.2017.11.007

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  7 in total

1.  A first investigation of tongue, lip, and jaw movements in persons with dysarthria due to multiple sclerosis.

Authors:  Antje S Mefferd; Abish Lai; Francesca Bagnato
Journal:  Mult Scler Relat Disord       Date:  2018-10-30       Impact factor: 4.339

Review 2.  Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice.

Authors:  Guy Fagherazzi; Aurélie Fischer; Muhannad Ismael; Vladimir Despotovic
Journal:  Digit Biomark       Date:  2021-04-16

Review 3.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

4.  Validation of an Acoustic-Based Framework of Speech Motor Control: Assessing Criterion and Construct Validity Using Kinematic and Perceptual Measures.

Authors:  Hannah P Rowe; Kaila L Stipancic; Adam C Lammert; Jordan R Green
Journal:  J Speech Lang Hear Res       Date:  2021-11-04       Impact factor: 2.674

5.  Motor speech patterns in Huntington disease.

Authors:  Sarah K Diehl; Antje S Mefferd; Ya-Chen Lin; Jessie Sellers; Katherine E McDonell; Michael de Riesthal; Daniel O Claassen
Journal:  Neurology       Date:  2019-10-29       Impact factor: 9.910

6.  Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran.

Authors:  Fereshteh Shamsian; Roshanak Mehdipour Dastjerdi; Arian Kavosh; Fereshteh Ashtari
Journal:  J Res Med Sci       Date:  2019-12-23       Impact factor: 1.852

Review 7.  Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination.

Authors:  Victor Longoria; Hannah Parcel; Bameelia Toma; Annu Minhas; Rana Zeine
Journal:  Biomedicines       Date:  2022-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.